site

commit dce1764eb82ec253727099c022e6890fd6054609
parent 15baea2ab74a7bb0c79bc6d4e76c77fb713426b6
Author: Beau <cbeauhilton@gmail.com>
Date:   Fri, 29 Mar 2024 14:45:11 -0500

update

Diffstat:
M
site/posts/s1.md
 | 
2
+-

1 file changed, 1 insertion(+), 1 deletion(-)
diff --git a/site/posts/s1.md b/site/posts/s1.md
@@ -120,7 +120,7 @@ it has orphan designation but is not approved for anything)
 
 They looked at 161 patients who qualified for 5-FU-based monotherapy for 
 metastatic colorectal cancer. 
-Combination drug therapy is the standard of care in this setting,
+Combination drug therapy is the standard of care frontline therapy in the metastatic setting,
 but monotherapy is a reasonable option for older and more frail patients,
 which is who this trial enrolled.
 They were randomized to S1 vs capecitabine,